A new study suggests that a drug Nonsteroidal anti-inflammatory (NSAIDs) that helps control the pain and inflammation in individuals with osteoarthritis (OA) may lead to cardiovascular diseases. The study published in the journal Arthritis & Rheumatology matched 7743 OA patients with 23229 non-OA controls. The risk of developing cardiovascular disease among people with OA was 23 per cent higher compared with people without OA. Among secondary outcomes assessed in the study the risk of congestive heart failure was 42 per cent higher among people with OA compared with people without OA followed by a 17 per cent greater risk of
